Catecholamine uptake, accumulation, and release in acute porphyria

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Acute porphyria is characterized by hypertension and tachycardia, linked to elevated catecholamines.
• The precise mechanism behind increased catecholamine levels in acute porphyria remains unclear.

Purpose of the Study:

• To investigate the mechanism of increased circulating catecholamines in acute porphyria.
• To determine if delta-aminolevulinate (ALA) or porphobilinogen (PBG) affect catecholamine uptake in adrenergic neurons.

Main Methods:

• Utilized isolated perfused rat heart and human platelets as models for adrenergic neuronal function.
• Assessed the uptake of [(3)H]norepinephrine in platelets from acute porphyria patients and normal controls in the presence of ALA or PBG.

Main Results:

• Neither ALA nor PBG affected catecholamine uptake or release in the isolated perfused rat heart.
• ALA and PBG significantly reduced [(3)H]-norepinephrine uptake and accumulation in platelets from acute porphyria patients.
• No reduction in norepinephrine uptake was observed in platelets from normal controls.

Conclusions:

• A latent defect in catecholamine uptake/accumulation exists in platelets of acute porphyria patients, unmasked by ALA or PBG.
• This defect in platelet uptake may model adrenergic neuron function.
• Elevated catecholamines during acute porphyria attacks may result from impaired re-uptake into sympathetic neurons.